EDGAR ENGLEMAN, Director, Ten Percent Owner at Soleno Therapeutics, holds 2.07M shares in Bolt Biotherapeutics (Ticker: BOLT), holds 4.03M shares in Soleno Therapeutics (Ticker: SLNO), holds 1.60M shares in Eiger Biopharmaceuticals (Ticker: EIGRQ). Most recently, EDGAR ENGLEMAN Sold ― shares of Bolt Biotherapeutics on Dec 01, 2023 for an estimated value of 127.84K.